In Brief: Sequana
Executive Summary
Sequana: Joint venture formed by the genomics firm and Memorial Sloan-Kettering Cancer Center for cancer genetic research. The joint venture, which will be called Genos Biosciences, will receive $5 mil. from Sequana and $5 mil. from Sloan-Kettering in funding. Sequana will provide the joint venture with gene discovery capabilities including genome scanning, DNA sequencing and bioinformatics, while Sloan-Kettering will supply a 30-year retrospective database of patient tumor-tissue samples...